HER2 amplification was more frequently associated with high tumor stage (FIGO III/IV), the GAC type, PNI and ovarian spread (p < 0.05) while IHC 3+ was more common in patients with LVI and ovarian involvement (p < 0.05) (Table 2). The gene discussed is ERBB2; the disease is neoplasm.